Cargando…

Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment

Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typi...

Descripción completa

Detalles Bibliográficos
Autores principales: Litwin, Tomasz, Dusek, Petr, Szafrański, Tomasz, Dzieżyc, Karolina, Członkowska, Anna, Rybakowski, Janusz K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022881/
https://www.ncbi.nlm.nih.gov/pubmed/29977520
http://dx.doi.org/10.1177/2045125318759461
_version_ 1783335754689150976
author Litwin, Tomasz
Dusek, Petr
Szafrański, Tomasz
Dzieżyc, Karolina
Członkowska, Anna
Rybakowski, Janusz K.
author_facet Litwin, Tomasz
Dusek, Petr
Szafrański, Tomasz
Dzieżyc, Karolina
Członkowska, Anna
Rybakowski, Janusz K.
author_sort Litwin, Tomasz
collection PubMed
description Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy.
format Online
Article
Text
id pubmed-6022881
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-60228812018-07-06 Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment Litwin, Tomasz Dusek, Petr Szafrański, Tomasz Dzieżyc, Karolina Członkowska, Anna Rybakowski, Janusz K. Ther Adv Psychopharmacol Review Article Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy. SAGE Publications 2018-03-06 2018-07 /pmc/articles/PMC6022881/ /pubmed/29977520 http://dx.doi.org/10.1177/2045125318759461 Text en © The Author(s), 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Article
Litwin, Tomasz
Dusek, Petr
Szafrański, Tomasz
Dzieżyc, Karolina
Członkowska, Anna
Rybakowski, Janusz K.
Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
title Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
title_full Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
title_fullStr Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
title_full_unstemmed Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
title_short Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
title_sort psychiatric manifestations in wilson’s disease: possibilities and difficulties for treatment
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022881/
https://www.ncbi.nlm.nih.gov/pubmed/29977520
http://dx.doi.org/10.1177/2045125318759461
work_keys_str_mv AT litwintomasz psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment
AT dusekpetr psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment
AT szafranskitomasz psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment
AT dziezyckarolina psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment
AT członkowskaanna psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment
AT rybakowskijanuszk psychiatricmanifestationsinwilsonsdiseasepossibilitiesanddifficultiesfortreatment